AP NEWS

Global Microbiome Therapeutics & Diagnostics Market Analysis & Forecast to 2023 - ResearchAndMarkets.com

September 17, 2018

DUBLIN--(BUSINESS WIRE)--Sep 17, 2018--The “Global Microbiome Therapeutics & Diagnostics Market Analysis & Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.

The analysis indicates that the global microbiome therapeutic and diagnostic market is worth $1.13 billion in 2018 and will grow at a CAGR of 19.03% over five years to $2.7 billion in 2023.

This report provides a comprehensive overview of the size of the microbiome therapeutic and diagnostic market, segmentation of the market (Gastrointestinal, Metabolic, Cancer, Neurological, Autoimmune, Skin), key players and the potential of therapies that are in clinical trials.

The majority of the market will be dominated by microbiome based therapeutics, with an estimate of 90%, compared to 10% in microbiome diagnostics.

This report describes the evolution of such a prospective market in eight chapters supported by over 82 tables and figures in 165 pages.

Key Points Covered:

An overview of the human microbiome space that includes how the market is sub-divided into therapeutics (prebiotics, probiotics, fecal microbiota transplantation, small molecules) and diagnostics. Global microbiome market, global breakdown, application breakdown and leading market players Detailed account of the microbiome industry market by geography, indication and company profiles Profiles, pipeline products, financial analysis and business strategy of the major companies in this space Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for microbiome therapeutics and diagnostics Insight into the challenges faced by stakeholders Insight into the biobanking industry globally and its impact on the overall market Description and data for the prevalence of disease types that are addressed by harnessing the human microbiota Financial market forecast through 2023 with CAGR values of all market segments outlined in the objective SWOT analysis of the global market Geographical analysis and challenges within key topographies including North America, Europe, Asia/Pacific, Middle East/Africa, ROW Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Microbiome Overview

Chapter 3 Human Therapeutic and Diagnostic Pipeline Analysis

Chapter 4 Market Analysis & Forecast to 2023

Chapter 5 Market Drivers, Trends & SWOT Analysis

Chapter 6 Investment and Market Deals

Chapter 7 Venture Capital and The Microbiome

Chapter 8 Major Players and Company Profiles

4D PharmaAbbvieAllerganAssembly BiosciencesBristol Myers SquibbC3J TherapeuticsDa VolterraEnteromeFinch TherapeuticsImmuronMatrisys BioscienceMerckOselPfizerQuorum InnovationsRebiotixSecond GenomeSeres TherapeuticsSynlogicSynthetic BiologicsTakedaVedanta BiosciencesFor more information about this report visit https://www.researchandmarkets.com/research/dtjsvq/global_microbiome?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180917005334/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics,Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/17/2018 07:56 AM/DISC: 09/17/2018 07:56 AM

http://www.businesswire.com/news/home/20180917005334/en

AP RADIO
Update hourly